RBOT stock forecast
Our latest prediction for Vicarious Surgical Inc's stock price was made on the Nov. 25, 2022 when the stock price was at 3.62$.
In the short term (2weeks), RBOT's stock price should underperform the market by -2.81%. During that period the price should oscillate between -9.82% and +6.06%.
In the medium term (3months), RBOT's stock price should outperform the market by 3.09%. During that period the price should oscillate between -33.22% and +30.55%.Get email alerts
Create a solid portfolio with RBOT
About Vicarious Surgical Inc
Founded in 2014, Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs. The Company's novel surgical approach uses a combination of proprietary human-like surgical robots and advanced visualization to transport surgeons inside the patient to perform minimally invasive surgery. The Company's technology was granted the Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) in November 2019, marking the first, and only, surgical robot to receive this designation from the FDA. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Khosla Ventures, Eric Schmidt's Innovation Endeavors and Jerry Yang's AME Cloud Ventures. The Company is headquartered in Charlestown, MA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of None$ per share.
The book value per share is 0.69$
Three months stock forecastNov. 25, 2022
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|